Motif ID: Klf4_Sp3
Z-value: 1.273
Transcription factors associated with Klf4_Sp3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Klf4 | ENSMUSG00000003032.8 | Klf4 |
| Sp3 | ENSMUSG00000027109.10 | Sp3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Klf4 | mm10_v2_chr4_-_55532453_55532485 | -0.09 | 6.0e-01 | Click! |
| Sp3 | mm10_v2_chr2_-_72980402_72980471 | -0.03 | 8.4e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 8.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 2.4 | 7.3 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 2.2 | 6.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 2.1 | 6.4 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 2.0 | 6.0 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
| 2.0 | 7.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 1.9 | 5.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 1.8 | 7.1 | GO:0003360 | brainstem development(GO:0003360) |
| 1.7 | 1.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 1.6 | 4.9 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 1.6 | 8.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.6 | 11.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.6 | 1.6 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 1.5 | 4.5 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.5 | 4.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 1.5 | 7.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 1.4 | 5.7 | GO:0030091 | protein repair(GO:0030091) |
| 1.4 | 2.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.4 | 4.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 1.3 | 4.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 1.3 | 9.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 1.3 | 1.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 1.3 | 3.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.2 | 3.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.2 | 3.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 1.2 | 6.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.2 | 3.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 1.2 | 3.7 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.2 | 10.4 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 1.1 | 10.3 | GO:0001842 | neural fold formation(GO:0001842) |
| 1.1 | 3.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.1 | 14.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.1 | 3.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.1 | 5.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 1.1 | 4.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.1 | 5.4 | GO:0015671 | oxygen transport(GO:0015671) |
| 1.1 | 3.2 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.1 | 4.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 1.1 | 3.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.1 | 1.1 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 1.0 | 2.1 | GO:1904347 | intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
| 1.0 | 1.0 | GO:1900141 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
| 1.0 | 4.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.0 | 3.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 1.0 | 1.0 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 1.0 | 3.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 1.0 | 1.9 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.9 | 3.8 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.9 | 4.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.9 | 3.7 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 | 6.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.9 | 7.2 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.9 | 3.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.9 | 6.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.9 | 0.9 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.9 | 0.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.9 | 2.6 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.8 | 2.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.8 | 3.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 0.8 | 2.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.8 | 5.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.8 | 1.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.8 | 1.6 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.8 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.8 | 2.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.8 | 2.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 | 0.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.8 | 9.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.8 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.8 | 8.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.8 | 3.2 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.8 | 3.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.8 | 4.0 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.8 | 3.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.8 | 3.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.8 | 3.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.8 | 3.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.8 | 4.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.8 | 3.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.8 | 2.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.8 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 0.8 | 9.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.8 | 1.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.8 | 2.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.8 | 5.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.8 | 5.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.8 | 4.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.7 | 2.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.7 | 3.0 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.7 | 0.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.7 | 3.0 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.7 | 4.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.7 | 2.9 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.7 | 2.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 | 2.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.7 | 5.0 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
| 0.7 | 6.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.7 | 0.7 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.7 | 1.4 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
| 0.7 | 0.7 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.7 | 2.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.7 | 2.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.7 | 1.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.7 | 1.4 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
| 0.7 | 1.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.7 | 1.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.7 | 10.9 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.7 | 2.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.7 | 0.7 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
| 0.7 | 2.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.7 | 1.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.7 | 2.0 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.7 | 2.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.7 | 1.3 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.7 | 4.0 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.7 | 2.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 | 1.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
| 0.7 | 4.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.7 | 4.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.7 | 2.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.7 | 3.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.6 | 1.3 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.6 | 2.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.6 | 3.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.6 | 1.9 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.6 | 2.5 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.6 | 1.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.6 | 0.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.6 | 0.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.6 | 4.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.6 | 4.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.6 | 1.2 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.6 | 4.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.6 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.6 | 2.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.6 | 1.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.6 | 4.9 | GO:0031424 | keratinization(GO:0031424) |
| 0.6 | 1.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.6 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.6 | 1.8 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.6 | 1.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.6 | 3.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 2.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.6 | 1.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.6 | 1.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.6 | 4.7 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.6 | 1.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.6 | 9.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
| 0.6 | 2.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.6 | 2.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.6 | 2.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.6 | 1.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.6 | 5.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.6 | 0.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.6 | 1.7 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 | 2.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.6 | 1.7 | GO:0060023 | soft palate development(GO:0060023) |
| 0.6 | 1.1 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.5 | 0.5 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.5 | 1.6 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.5 | 0.5 | GO:0080144 | amino acid homeostasis(GO:0080144) |
| 0.5 | 6.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.5 | 1.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.5 | 1.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.5 | 0.5 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.5 | 1.6 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
| 0.5 | 1.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 | 2.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.5 | 1.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.5 | 1.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.5 | 2.6 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.5 | 0.5 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
| 0.5 | 1.6 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.5 | 5.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.5 | 1.0 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.5 | 2.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 | 8.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.5 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.5 | 4.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.5 | 3.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 | 1.0 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
| 0.5 | 1.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.5 | 1.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.5 | 6.0 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.5 | 6.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.5 | 1.5 | GO:0033504 | floor plate development(GO:0033504) |
| 0.5 | 1.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 2.0 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.5 | 7.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.5 | 2.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 | 1.0 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 | 2.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.5 | 5.4 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
| 0.5 | 4.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 | 5.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.5 | 2.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 1.5 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.5 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.5 | 1.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.5 | 2.4 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.5 | 2.9 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.5 | 2.4 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 | 1.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.5 | 1.5 | GO:0036258 | multivesicular body assembly(GO:0036258) |
| 0.5 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.5 | 4.8 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.5 | 1.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.5 | 1.0 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.5 | 5.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.5 | 2.4 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.5 | 1.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.5 | 1.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.5 | 1.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.5 | 3.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.5 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.5 | 1.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.5 | 2.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.5 | 2.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.5 | 2.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.5 | 1.4 | GO:1902071 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.5 | 0.9 | GO:0036166 | phenotypic switching(GO:0036166) |
| 0.5 | 1.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.5 | 1.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.5 | 3.7 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.5 | 1.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.5 | 10.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 | 0.4 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 0.4 | 3.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.4 | 2.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.4 | 3.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.4 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.4 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.4 | 3.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.4 | 4.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.4 | 0.9 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.4 | 2.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.4 | 1.7 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.4 | 4.8 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.4 | 3.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.4 | 1.7 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.4 | 1.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 | 0.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.4 | 0.4 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 | 1.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.4 | 0.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.4 | 0.4 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.4 | 0.4 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.4 | 0.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 | 2.5 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.4 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.4 | 2.5 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.4 | 1.3 | GO:0016554 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
| 0.4 | 0.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 | 0.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 | 0.4 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.4 | 1.2 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 | 2.9 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.4 | 0.8 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.4 | 0.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.4 | 5.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.4 | 4.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.4 | 1.2 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.4 | 7.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.4 | 1.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.4 | 1.2 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.4 | 4.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 | 1.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.4 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.4 | 1.9 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.4 | 0.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.4 | 4.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 | 0.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.4 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.4 | 1.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.4 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 4.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.4 | 1.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.4 | 5.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.4 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.4 | 0.7 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.4 | 3.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 2.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.4 | 3.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 1.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.4 | 8.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.4 | 0.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.4 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.4 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
| 0.4 | 11.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.4 | 1.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.4 | 1.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.4 | 0.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 0.4 | 0.7 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.4 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 | 1.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.4 | 1.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 2.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 | 1.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.4 | 4.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.4 | 15.8 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.4 | 1.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 | 0.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.4 | 4.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.4 | 1.8 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.4 | 2.5 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.4 | 1.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.4 | 6.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.4 | 4.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.4 | 2.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.4 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 4.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 2.1 | GO:0032439 | endosome localization(GO:0032439) |
| 0.3 | 9.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 4.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.3 | 0.7 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 | 7.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.3 | 4.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.3 | 1.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.3 | 1.0 | GO:0060513 | prostatic bud formation(GO:0060513) |
| 0.3 | 1.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.3 | 1.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 | 1.0 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.3 | 1.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.3 | 1.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.3 | 1.0 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.3 | 0.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.3 | 1.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 | 1.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.3 | 1.0 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.3 | 1.3 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 0.3 | 2.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.3 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.3 | 1.6 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.3 | 0.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 0.3 | 1.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 | 0.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 | 1.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.3 | 1.9 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
| 0.3 | 2.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.3 | 3.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.3 | 1.9 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.3 | 0.9 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.3 | 2.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.3 | 0.6 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.3 | 0.9 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.3 | 2.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
| 0.3 | 4.0 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.3 | 5.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 | 0.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.3 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 0.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.3 | 1.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 | 3.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 | 4.7 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.3 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.3 | 2.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.3 | 1.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.3 | 2.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 | 1.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 | 1.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.3 | 1.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.3 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.3 | 0.6 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 | 0.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.3 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.3 | 0.6 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.3 | 1.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.3 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.3 | 1.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.3 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.3 | 5.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.3 | 0.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.3 | 0.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.3 | 2.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 | 1.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 | 10.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
| 0.3 | 3.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.3 | 1.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.3 | 0.5 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
| 0.3 | 0.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.3 | 1.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 | 1.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.3 | 4.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 | 2.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 0.8 | GO:1990859 | cellular response to endothelin(GO:1990859) |
| 0.3 | 0.8 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.3 | 0.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.3 | 5.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 0.3 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.3 | 1.3 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
| 0.3 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 | 2.3 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.3 | 0.5 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.3 | 0.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.3 | 0.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 0.3 | 0.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 | 0.3 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 | 3.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.2 | 1.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 | 2.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 | 1.5 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.2 | 1.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.2 | 2.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 2.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.2 | 2.0 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 | 0.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 9.6 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.2 | 0.5 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.2 | 0.2 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 0.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.2 | 7.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 1.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.2 | 1.0 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) regulation of cholesterol import(GO:0060620) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) regulation of sterol import(GO:2000909) positive regulation of sterol import(GO:2000911) |
| 0.2 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.2 | 6.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 3.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 1.7 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 0.2 | 0.7 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 | 1.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.2 | 3.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.2 | 0.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.2 | 4.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 1.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.2 | 1.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 0.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 | 1.4 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.2 | 0.2 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) |
| 0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.2 | 2.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.2 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.2 | 0.2 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 0.7 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 1.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.2 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.2 | 1.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 | 2.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 1.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 1.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 2.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 | 2.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.2 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 1.6 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.2 | 0.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.2 | 1.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.2 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.2 | 0.2 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
| 0.2 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 1.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 2.4 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 1.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.2 | 0.2 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 1.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 2.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.4 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.2 | 1.1 | GO:0032796 | uropod organization(GO:0032796) |
| 0.2 | 0.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 1.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.2 | 0.6 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.2 | 0.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 0.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.2 | 2.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.2 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
| 0.2 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.2 | 0.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 | 0.8 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.2 | 1.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.2 | 1.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.2 | 0.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.2 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.2 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 1.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 1.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 0.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.2 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 3.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 1.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 0.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 | 0.2 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.2 | 0.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 | 5.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 | 0.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 | 0.2 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.2 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.2 | 0.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 0.2 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.2 | 0.2 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.2 | 0.8 | GO:0071599 | otic vesicle development(GO:0071599) |
| 0.2 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 1.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.2 | 0.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 1.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 | 2.0 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 | 1.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.2 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 0.8 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.2 | 0.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 | 1.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
| 0.2 | 0.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 0.2 | 1.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 9.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.2 | 1.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 | 4.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 0.6 | GO:0032303 | regulation of icosanoid secretion(GO:0032303) |
| 0.2 | 0.9 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.2 | 1.9 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 0.2 | 3.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.2 | 1.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.2 | 2.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.2 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.2 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 1.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.2 | 0.5 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.2 | 1.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 | 1.6 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.2 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 1.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.2 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 0.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 0.3 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.2 | 0.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.2 | 0.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 1.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 | 1.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.2 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
| 0.2 | 1.9 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.2 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 1.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 | 1.2 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.2 | 0.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) regulation of translation in response to stress(GO:0043555) |
| 0.2 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.2 | 0.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.2 | 2.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.2 | 0.5 | GO:0072217 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) negative regulation of metanephros development(GO:0072217) |
| 0.2 | 0.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.2 | 0.3 | GO:0033260 | nuclear DNA replication(GO:0033260) cell cycle DNA replication(GO:0044786) |
| 0.2 | 5.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.2 | 4.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.2 | 0.8 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 | 0.5 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.2 | 2.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 | 0.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 | 1.3 | GO:0015791 | polyol transport(GO:0015791) |
| 0.2 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 0.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 | 1.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.2 | 0.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 1.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.2 | 0.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.2 | 0.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.2 | 0.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
| 0.2 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.2 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.2 | 0.5 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 | 0.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.2 | 2.4 | GO:0007530 | sex determination(GO:0007530) |
| 0.2 | 0.2 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.2 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.2 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 | 4.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 0.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 | 0.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.2 | 0.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.2 | 0.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.2 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 0.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.2 | 0.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 0.6 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.2 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.1 | 1.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 0.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.1 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 | 3.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 1.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.1 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
| 0.1 | 1.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.4 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.3 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) endothelial cell fate commitment(GO:0060839) |
| 0.1 | 2.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.1 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.1 | 1.6 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
| 0.1 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 0.1 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.1 | 0.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 8.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 0.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 1.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.7 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
| 0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.4 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.1 | 0.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 1.9 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.4 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.1 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.1 | 1.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.1 | 5.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.4 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.1 | 0.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 | 1.3 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 | 2.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
| 0.1 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 0.9 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 0.8 | GO:0071548 | response to dexamethasone(GO:0071548) |
| 0.1 | 2.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 0.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.1 | 0.1 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 1.5 | GO:0007549 | dosage compensation(GO:0007549) |
| 0.1 | 0.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 | 1.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 1.7 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.1 | 1.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.1 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 1.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
| 0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.1 | 0.9 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.1 | 1.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.1 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 | 0.1 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 2.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.4 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.1 | 1.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.4 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.1 | 0.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 3.5 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.1 | 0.8 | GO:0035510 | DNA dealkylation(GO:0035510) |
| 0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 1.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 0.4 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
| 0.1 | 1.5 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
| 0.1 | 0.3 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 | 0.1 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.1 | 1.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 1.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.1 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.7 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 1.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
| 0.1 | 2.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.1 | 2.5 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 | 0.6 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 | 3.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.1 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.1 | 2.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 1.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 2.4 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.2 | GO:2000834 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) negative regulation of glucagon secretion(GO:0070093) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 | 0.2 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 1.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.2 | GO:2000620 | regulation of histone H4-K16 acetylation(GO:2000618) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 | 0.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.4 | GO:0051340 | regulation of ligase activity(GO:0051340) |
| 0.1 | 0.2 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 | 0.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.1 | 1.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.4 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 0.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.1 | 3.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.4 | GO:0052490 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) synaptic vesicle recycling via endosome(GO:0036466) modulation by virus of host apoptotic process(GO:0039526) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.1 | 0.9 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 0.2 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.1 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.4 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.9 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.1 | 0.5 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.1 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.1 | 1.0 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
| 0.1 | 1.4 | GO:0010586 | miRNA metabolic process(GO:0010586) |
| 0.1 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.1 | 1.4 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.1 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 1.5 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.1 | 0.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 3.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.1 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 | 0.3 | GO:0044782 | cilium organization(GO:0044782) |
| 0.1 | 0.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.1 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 2.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.3 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.1 | 0.2 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.3 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
| 0.1 | 0.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 2.8 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 1.2 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
| 0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 5.8 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 0.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.1 | 0.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
| 0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.1 | 1.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 1.9 | GO:0070265 | necrotic cell death(GO:0070265) |
| 0.1 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.2 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) acetate ester transport(GO:1901374) |
| 0.1 | 1.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
| 0.1 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.3 | GO:0007296 | cytoplasm organization(GO:0007028) vitellogenesis(GO:0007296) |
| 0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 | 0.1 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 | 0.2 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 | 3.1 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.1 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.1 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.1 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
| 0.1 | 0.1 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 0.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.1 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.1 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.1 | GO:0070474 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 0.3 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 0.8 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 0.3 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 1.7 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.2 | GO:0048308 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 | 1.7 | GO:0042384 | cilium assembly(GO:0042384) |
| 0.1 | 0.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.1 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 | 0.1 | GO:0015961 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.1 | 1.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 | 1.9 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 | 0.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 0.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.1 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 0.2 | GO:0046471 | cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.1 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.2 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.1 | 0.6 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 0.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.1 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.8 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 | 0.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 | 0.1 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.0 | 0.0 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.0 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.0 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.0 | 0.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.0 | 1.2 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.0 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.0 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 | 0.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.1 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.0 | 0.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 | 0.7 | GO:0006414 | translational elongation(GO:0006414) |
| 0.0 | 0.2 | GO:1903236 | negative regulation of cellular extravasation(GO:0002692) regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 0.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
| 0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.0 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.0 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
| 0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 | 0.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.0 | 0.0 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.0 | 0.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 1.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.0 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 | 0.2 | GO:0051299 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) centrosome separation(GO:0051299) |
| 0.0 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 | 0.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.6 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 | 0.0 | GO:0048793 | pronephros development(GO:0048793) |
| 0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.2 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 | 0.2 | GO:0099639 | endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.0 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
| 0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.0 | 0.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.0 | 0.1 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.0 | 0.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 | 0.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 | 0.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 | 1.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.0 | 0.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.3 | GO:0007098 | centrosome cycle(GO:0007098) |
| 0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.0 | 0.1 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.0 | 1.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.0 | 0.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.0 | 0.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 | 0.6 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 | 0.0 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 0.1 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 0.0 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.0 | 0.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.0 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 | 1.4 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 0.0 | GO:0010934 | macrophage cytokine production(GO:0010934) |
| 0.0 | 1.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 1.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
| 0.0 | 0.0 | GO:0043489 | RNA stabilization(GO:0043489) |
| 0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.0 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
| 0.0 | 0.0 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.0 | 0.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.0 | 0.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
| 0.0 | 0.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 | 0.8 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 | 0.0 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.0 | 0.1 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.0 | 0.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.0 | 0.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 | 0.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
| 0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.0 | 0.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.0 | 0.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.0 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.0 | 0.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.0 | 0.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 2.0 | 2.0 | GO:0044427 | chromosomal part(GO:0044427) |
| 1.5 | 6.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.3 | 3.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 1.2 | 1.2 | GO:0042585 | germinal vesicle(GO:0042585) |
| 1.2 | 5.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.1 | 4.6 | GO:0090537 | CERF complex(GO:0090537) |
| 1.1 | 2.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 1.1 | 6.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 1.1 | 3.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.0 | 2.9 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.9 | 5.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.9 | 3.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.9 | 7.8 | GO:0005883 | neurofilament(GO:0005883) |
| 0.8 | 2.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.8 | 5.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.8 | 3.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.8 | 5.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.8 | 4.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.8 | 13.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.8 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.8 | 2.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.7 | 4.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.7 | 4.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.7 | 3.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.7 | 6.6 | GO:0090543 | Flemming body(GO:0090543) |
| 0.7 | 2.0 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.7 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.6 | 1.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.6 | 10.0 | GO:0043196 | varicosity(GO:0043196) |
| 0.6 | 2.4 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.6 | 3.6 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.6 | 2.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.6 | 4.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.6 | 2.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.6 | 1.1 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.5 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 2.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.5 | 2.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.5 | 6.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.5 | 12.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.5 | 7.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.5 | 4.5 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.5 | 1.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.5 | 2.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.5 | 7.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.5 | 1.4 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.5 | 4.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.5 | 3.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.5 | 0.5 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 0.4 | 1.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.4 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 7.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 7.1 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 3.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.4 | 4.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.4 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 3.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.4 | 1.2 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
| 0.4 | 2.0 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.4 | 1.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 0.4 | 1.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.4 | 2.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 2.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 3.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 2.7 | GO:0001740 | Barr body(GO:0001740) |
| 0.4 | 3.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.4 | 4.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.4 | 3.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.4 | 1.1 | GO:0031417 | NatC complex(GO:0031417) |
| 0.4 | 2.2 | GO:0045179 | apical cortex(GO:0045179) |
| 0.4 | 1.1 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 5.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.4 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 16.0 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 2.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.4 | 4.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.4 | 2.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.4 | 3.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.4 | 4.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.4 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.3 | 1.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.3 | 8.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.3 | 1.0 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.3 | 2.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 3.3 | GO:0000796 | condensin complex(GO:0000796) |
| 0.3 | 2.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.3 | 2.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.3 | 1.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.3 | 1.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.3 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 5.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.3 | 0.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.3 | 0.9 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.3 | 3.9 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.3 | 2.1 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.3 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.3 | 2.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.3 | 0.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 1.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.3 | 0.8 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.3 | 0.8 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.3 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
| 0.3 | 2.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 3.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 1.4 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 4.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 3.2 | GO:0045120 | pronucleus(GO:0045120) |
| 0.3 | 2.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.3 | 3.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.3 | 1.6 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.3 | 3.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.3 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.3 | 1.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.3 | 1.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.3 | 15.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.3 | 2.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.3 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 1.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.3 | 2.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.3 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.2 | 0.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 1.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 4.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 0.5 | GO:1990752 | microtubule end(GO:1990752) |
| 0.2 | 4.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 3.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 2.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 1.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.2 | 3.1 | GO:0031105 | septin complex(GO:0031105) |
| 0.2 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 0.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 2.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 1.8 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.2 | 0.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.2 | 2.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 0.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 0.7 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
| 0.2 | 0.7 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 0.2 | 2.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.2 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 2.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 3.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.2 | 3.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 3.3 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.2 | 0.4 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
| 0.2 | 1.0 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.2 | 2.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.8 | GO:0008623 | CHRAC(GO:0008623) |
| 0.2 | 1.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.2 | 5.0 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.2 | 2.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 2.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 6.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 2.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 16.4 | GO:0000776 | kinetochore(GO:0000776) |
| 0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 1.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 0.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.2 | 0.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 2.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.2 | 0.9 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 0.9 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 1.6 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 5.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 2.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 0.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.2 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.2 | 2.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.2 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.2 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.2 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.2 | 2.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.2 | 5.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 0.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 9.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 1.9 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 0.5 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.2 | 1.3 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 2.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 7.0 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 0.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.2 | 0.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.2 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 2.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 0.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
| 0.2 | 1.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.7 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.1 | 15.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 1.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.1 | 2.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.1 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 1.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.5 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 5.6 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 1.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.1 | 0.5 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
| 0.1 | 5.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 6.1 | GO:0022627 | small ribosomal subunit(GO:0015935) cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 7.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 5.1 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 2.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.1 | 5.0 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 1.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 3.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 6.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 11.0 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 1.5 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 2.1 | GO:0030286 | dynein complex(GO:0030286) |
| 0.1 | 6.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.1 | 5.0 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 1.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.1 | 6.0 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.1 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 1.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 2.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 0.5 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 0.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.1 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.1 | 2.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.1 | 4.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.1 | 1.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 2.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 3.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 1.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.1 | 0.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 3.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 5.0 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 4.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 16.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 1.1 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 3.8 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 1.3 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 2.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 0.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 1.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
| 0.0 | 0.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.0 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.0 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 2.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 2.3 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.3 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 2.4 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.0 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
| 0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 1.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.0 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
| 0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
| 0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 0.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.0 | 0.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.0 | 0.5 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 0.7 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 0.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.1 | GO:0044450 | microtubule organizing center part(GO:0044450) |
| 0.0 | 0.2 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
| 0.0 | 2.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 8.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 2.7 | 8.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 2.4 | 7.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 2.3 | 11.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 2.1 | 8.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.8 | 7.3 | GO:0070976 | TIR domain binding(GO:0070976) |
| 1.8 | 7.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.7 | 6.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 1.5 | 4.5 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.5 | 4.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
| 1.4 | 4.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 1.3 | 3.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 1.3 | 3.8 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 1.2 | 3.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 1.2 | 1.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
| 1.2 | 6.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 1.1 | 2.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.1 | 5.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 1.1 | 3.3 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 1.1 | 8.7 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.1 | 5.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 1.0 | 5.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.0 | 6.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 1.0 | 3.1 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 1.0 | 3.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.0 | 3.0 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.0 | 5.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.0 | 1.0 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.9 | 5.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.9 | 2.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.9 | 2.6 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.9 | 5.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.8 | 2.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.8 | 1.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.8 | 6.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.8 | 2.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.8 | 3.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.8 | 4.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.7 | 1.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.7 | 2.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.7 | 2.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.7 | 4.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.7 | 2.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.7 | 2.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.7 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.7 | 9.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.7 | 1.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.7 | 4.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.7 | 4.7 | GO:0048185 | activin binding(GO:0048185) |
| 0.7 | 9.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.7 | 2.0 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.7 | 2.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.7 | 10.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.7 | 2.0 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 0.7 | 2.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.7 | 4.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.6 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.6 | 5.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.6 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.6 | 1.8 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.6 | 2.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.6 | 7.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.6 | 3.0 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.6 | 4.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.6 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.6 | 2.3 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.6 | 5.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.6 | 6.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.6 | 5.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.6 | 6.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.6 | 3.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.6 | 2.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.6 | 3.9 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 0.6 | 3.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.6 | 3.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.5 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.5 | 1.6 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 0.5 | 2.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.5 | 3.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.5 | 2.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.5 | 2.6 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.5 | 3.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.5 | 11.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.5 | 2.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.5 | 1.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.5 | 2.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.5 | 3.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.5 | 1.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.5 | 0.5 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.5 | 3.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.5 | 1.9 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 0.5 | 1.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.5 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.5 | 1.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.5 | 4.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 1.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.5 | 1.4 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.5 | 1.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.5 | 13.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.5 | 1.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.4 | 1.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.4 | 21.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.4 | 1.8 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.4 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 1.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.4 | 4.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.4 | 1.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.4 | 17.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.4 | 1.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 1.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.4 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 1.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 2.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.4 | 2.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.4 | 1.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.4 | 0.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.4 | 8.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.4 | 2.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 1.6 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.4 | 2.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.4 | 1.2 | GO:0004096 | catalase activity(GO:0004096) |
| 0.4 | 2.4 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.4 | 2.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.4 | 2.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 0.8 | GO:0051379 | epinephrine binding(GO:0051379) |
| 0.4 | 4.7 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.4 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.4 | 3.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.4 | 1.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.4 | 1.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.4 | 1.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.4 | 2.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.4 | 8.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.4 | 2.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.4 | 1.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.4 | 1.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.4 | 4.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.4 | 2.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 2.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.4 | 5.0 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 1.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.4 | 2.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 1.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.3 | 0.7 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.3 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 13.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.3 | 1.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.3 | 15.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.3 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.3 | 1.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.3 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.3 | 1.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.3 | 4.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.3 | 13.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.3 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.3 | 2.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 0.9 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.3 | 2.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 4.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.3 | 1.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 2.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.3 | 0.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.3 | 0.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.3 | 1.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.3 | 0.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.3 | 3.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.3 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.3 | 2.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.3 | 2.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.3 | 4.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 1.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 1.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.3 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 2.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.3 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.3 | 3.6 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
| 0.3 | 2.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.3 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.3 | 1.2 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.3 | 8.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.3 | 1.2 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.3 | 0.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.3 | 1.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.3 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.3 | 1.1 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.3 | 1.4 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 1.9 | GO:0070061 | fructose binding(GO:0070061) |
| 0.3 | 1.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.3 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.3 | 1.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.3 | 2.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.3 | 0.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.3 | 2.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.3 | 0.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.3 | 2.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.2 | 0.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.2 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.2 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 1.0 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
| 0.2 | 2.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 0.5 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.2 | 0.7 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 1.9 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.2 | 3.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 0.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.2 | 2.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 0.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.2 | 2.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 2.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.2 | 5.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 1.6 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 2.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 3.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 1.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.2 | 0.9 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.2 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 0.7 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
| 0.2 | 1.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.2 | 2.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 0.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 0.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.2 | 1.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.2 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 0.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 3.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 1.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.2 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.2 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 0.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.2 | 1.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.2 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 3.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.2 | 6.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 9.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.2 | 1.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 3.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 0.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.2 | 1.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 0.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 0.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.2 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 0.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 3.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 0.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.2 | 6.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 2.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 1.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.2 | 0.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 0.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 1.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 0.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 1.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 12.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.2 | 2.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.2 | 8.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 1.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
| 0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 2.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 3.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 5.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 3.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 8.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 1.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.2 | 2.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 3.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 1.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.2 | 0.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 1.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 0.6 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 3.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 3.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 0.8 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.2 | 0.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.2 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.2 | 5.2 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.2 | 4.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.2 | 0.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.2 | 2.1 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 1.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 0.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.2 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 0.6 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
| 0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 4.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 24.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 1.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 3.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 1.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 3.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 1.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 2.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 1.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 2.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 3.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 1.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 0.4 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.1 | 0.9 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 0.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 2.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 6.9 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 0.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
| 0.1 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.1 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 2.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 6.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.1 | 1.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 1.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 0.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 0.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 7.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 1.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 3.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 1.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 1.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 1.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.1 | 0.4 | GO:0003681 | bent DNA binding(GO:0003681) |
| 0.1 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.1 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
| 0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 2.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 1.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.1 | 1.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.2 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 1.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 1.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.1 | 1.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
| 0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 5.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 1.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.1 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.1 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.1 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 1.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 0.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 1.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 4.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.1 | 0.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
| 0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 0.1 | GO:0032554 | deoxyribonucleotide binding(GO:0032552) purine deoxyribonucleotide binding(GO:0032554) |
| 0.1 | 0.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.1 | 1.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 0.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 3.2 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 12.6 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 1.2 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 0.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.1 | 0.2 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.1 | 0.8 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 0.1 | 0.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
| 0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.1 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 12.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.1 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.1 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.1 | 7.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 0.2 | GO:0032564 | dATP binding(GO:0032564) |
| 0.0 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.0 | 2.9 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.8 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.0 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.0 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.0 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.0 | 0.6 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.0 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.0 | 1.3 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.0 | 2.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.0 | 0.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 1.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
| 0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
| 0.0 | 2.2 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.0 | 2.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 5.1 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.0 | 0.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 0.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.0 | 0.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.0 | 0.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.0 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
| 0.0 | 1.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
| 0.0 | 2.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.1 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
| 0.0 | 0.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.0 | 0.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 0.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.0 | 0.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.0 | 0.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.0 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 12.8 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.9 | 1.7 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.5 | 9.7 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 0.5 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.5 | 4.0 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.5 | 30.4 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.5 | 17.2 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.4 | 17.4 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.4 | 9.7 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.4 | 12.5 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.4 | 0.4 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.3 | 3.1 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.3 | 8.6 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.3 | 4.7 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 28.6 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.3 | 6.7 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 10.4 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 0.8 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 12.1 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 7.1 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.2 | 5.2 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 1.9 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.2 | 21.8 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 1.1 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.2 | 0.4 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.2 | 6.0 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 0.2 | ST_STAT3_PATHWAY | STAT3 Pathway |
| 0.2 | 6.1 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.2 | 1.1 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 0.2 | 5.5 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.2 | 0.9 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 1.8 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.2 | 5.8 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 5.4 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.2 | 2.8 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 14.0 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 1.3 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 0.3 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 0.5 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.2 | 6.1 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.2 | 3.0 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.1 | 1.5 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.1 | 4.0 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.1 | 10.4 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 4.0 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 9.7 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 2.1 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 0.1 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.1 | 0.1 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 3.7 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.1 | 2.2 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.1 | 6.4 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.6 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 0.1 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 1.3 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.1 | 3.9 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.7 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.8 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 2.9 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.1 | 0.5 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 1.8 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.2 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 7.8 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.1 | 1.1 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.1 | 2.8 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 2.0 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
| 0.1 | 0.8 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.5 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.9 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.1 | 1.9 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.1 | 1.1 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 0.2 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 0.2 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 0.6 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 1.6 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 0.7 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.1 | 0.2 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 2.5 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.1 | 0.2 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 0.5 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 1.0 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 1.3 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.1 | 3.0 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.1 | 1.8 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 0.5 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.3 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 0.3 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.8 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.8 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 0.6 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 0.4 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.0 | 0.3 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.3 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.0 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.0 | 0.1 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 0.2 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.3 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.1 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.6 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.0 | 0.3 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.1 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 6.6 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.7 | 3.5 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.7 | 14.4 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.7 | 8.8 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.6 | 5.1 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.6 | 7.3 | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.6 | 8.4 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.6 | 5.4 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.5 | 4.3 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.5 | 11.8 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.5 | 10.6 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 0.5 | 14.2 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.5 | 2.0 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.5 | 12.6 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.5 | 0.9 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.5 | 10.2 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.5 | 1.4 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.4 | 5.4 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.4 | 15.1 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.4 | 4.1 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.4 | 8.9 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.4 | 8.4 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.4 | 12.0 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.4 | 0.8 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 9.3 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 0.4 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.4 | 7.7 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.4 | 0.4 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.4 | 3.2 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 11.7 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.3 | 10.2 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.3 | 4.9 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.3 | 12.6 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 2.9 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.3 | 4.9 | REACTOME_SIGNALING_BY_NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.3 | 7.0 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.3 | 2.1 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 26.7 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.3 | 11.8 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 5.3 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 1.4 | REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_ | Genes involved in Cyclin E associated events during G1/S transition |
| 0.3 | 7.2 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.3 | 0.3 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.3 | 2.9 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.3 | 0.3 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.3 | 3.9 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.3 | 0.8 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 0.7 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.2 | 2.7 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 26.8 | REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
| 0.2 | 3.0 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 11.9 | REACTOME_REGULATION_OF_APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.2 | 7.2 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 2.9 | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | Genes involved in G alpha (q) signalling events |
| 0.2 | 3.5 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 2.0 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 1.3 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.2 | 3.2 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 2.3 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 4.7 | REACTOME_G1_S_TRANSITION | Genes involved in G1/S Transition |
| 0.2 | 4.1 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 3.1 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.2 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.2 | 1.9 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 0.9 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 0.4 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 1.8 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 8.8 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.2 | 0.9 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 3.2 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 0.3 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 2.4 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 2.0 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 4.0 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 1.7 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.2 | 3.6 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 17.0 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 3.9 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.2 | 1.7 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 3.0 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 1.4 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.2 | 25.0 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.8 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 2.5 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.3 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.1 | 3.4 | REACTOME_INFLUENZA_LIFE_CYCLE | Genes involved in Influenza Life Cycle |
| 0.1 | 0.3 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
| 0.1 | 0.6 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 2.3 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 7.6 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 3.8 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 3.3 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.1 | 2.5 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 6.4 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 15.4 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 3.5 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.9 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 1.4 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 1.8 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 4.3 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 2.7 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.9 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 2.0 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.6 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 2.1 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 0.3 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 1.2 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 0.1 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 2.0 | REACTOME_SIGNALING_BY_NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.1 | 0.6 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 0.4 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.1 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 1.4 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 0.8 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 0.5 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 1.5 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 0.5 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 1.8 | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.1 | 0.1 | REACTOME_MITOTIC_M_M_G1_PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.1 | 4.1 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 0.7 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 2.9 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 2.2 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.5 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 0.7 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 0.5 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.1 | 3.2 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 0.9 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 0.3 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 2.0 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 4.2 | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 0.1 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 0.1 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 1.4 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.5 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 0.4 | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 0.3 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 0.2 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.0 | 0.6 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.2 | REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_ | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.0 | 0.7 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.4 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.7 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 1.6 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.5 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.8 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.1 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.8 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.4 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.5 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 4.1 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 0.2 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.6 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.4 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.7 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.5 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 1.1 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.0 | 0.1 | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | Genes involved in Signaling by FGFR in disease |
| 0.0 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 0.6 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.2 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.2 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.1 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
|
|
|